Successful Treatment of Multidrug-Resistant Tuberculous Meningitis in a Young Chinese Woman: A Case Study From Japan
Abstract
BACKGROUND Multidrug-resistant tuberculosis (MDR-TB) continues to pose a serious public health challenge, especially when associated with tuberculous meningitis (TBM), which complicates treatment due to the need for central nervous system (CNS) penetration and non-oral administration routes. This case report describes a 24-year-old woman with MDR pulmonary tuberculosis and tuberculous meningitis (TBM) successfully treated with a combination of pyrazinamide, levofloxacin, cycloserine, and linezolid. CASE REPORT A previously healthy 24-year-old woman from Jilin Province, China presented with fever, headache, and impaired consciousness. Chest computed tomography (CT) showed centrilobular nodules and tree-in-bud appearances, while magnetic resonance imaging (MRI) revealed basal meningeal enhancement and tuberculomas. Acid-fast bacilli (AFB) were detected on smear microscopy of cerebrospinal fluid (CSF), and culture confirmed Mycobacterium tuberculosis. Drug susceptibility testing confirmed MDR-TB. Due to impaired consciousness, the treatment regimen was selected based on CNS penetration and enteral administration compatibility. A combination of pyrazinamide, levofloxacin, cycloserine, and linezolid was administered over 18 months. Bedaquiline and pretomanid were not used due to insufficient CNS penetration data at the time and limited availability in Japan. The patient required prolonged mechanical ventilation and was discharged in a minimally conscious state after 541 days.…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.